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Abstract
Choledochocele represents a cystic dilatation of the 
distal common bile duct and it’s included in Todani’s 
classification as type III choledochal cysts. We report a 
case of a 66-years-old man who presented a suspected 
gallbladder lithiasis with colic abdominal pain, vomit, 
fever, jaundice and abnormal liver function tests. However 
the endoscopic retrograde cholangio-pancreatography 
revealed the absence of stones in the common bile 
duct and the presence of a 15mm-wide choledochocele 
that was successfully treated with an endoscopic 
sphincterotomy. Additionally a comprehensive review 
of the literature of the last 15 years was performed, 
collecting 105 cases of choledochocele. The available data 
were classified in 10 variables and subsequently analysed. 
Summarizing all data, we noticed that choledochocele 
presents different characteristics if compared with other 
types of choledochal cysts: The population affected 
is older, there isn’t a strong female prevalence, the 
most frequent manifestation is pancreatitis instead of 
jaundice and cholangitis, the association with anomalous 
pancreato-biliary duct junction is rare and the risk of 
malignancy is lower. The standard for the diagnosis is 
endoscopic retrograde cholangio-pancreatography instead 
of magnetic resonance cholangio-pancreatography and 
the most accepted treatment is endoscopic sphincterotomy 
in order to allow the correct outflow of the biliary juice. 
In conclusion, even if choledochocele is commonly 
considered a type of cystic dilatation of the common 
biliary duct and it is usually included in the choledochal 
cysts classification, it has to be considered as a distinct 
entity with its own features.
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INTRODUCTION
Choledochocele is a cystic dilatation of the intraduodenal 
portion of the common bile duct (CBD) and it protrudes 
into the duodenal lumen. It was first described by Wheeler 
et al1 in 1940 and, according to the Alonso and Todani’s 
classification (Figure 1)[2-3], it is considered as a type 
III choledochal cyst (CC). Despite choledochocele is 
described as the rarest subtype of CC, representing less 
than 5% of all reported cysts[4-5], recent studies observed 
an increasing incidence of choledochocele in the last 
years, probably due to the improvement of imaging 
techniques and to the growing experience with endoscopic 
procedure[6-7]. 
Figure 1
Biliary Cysts’s Classification 
Note. Type 1: solitary fusiform extrahepatic cyst. Type 2: extrahepatic 
supraduodenal diverticulum. Type 3: intraduodenal diverticulum 
(Choledochocele). Type 4a: fusiform extra and intrahepatic cyst. Type 
4b: multiple extrahepatic cysts. Type 5: multiple intrahepatic cysts 
(Caroli’s Disease)
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On the basis of the observations of Scholz et al.,[8] 
Sarris et al.[9] proposed an anatomic classification by 
subdividing choledochoceles into type A and type B 
(Figure 2). In type A, that is the most frequent variety, 
the ampulla opens into the choledochocele which, in 
turn, communicates with the duodenum through an own 
small orifice. In type B the ampulla empties directly 
into the duodenum and the choledochocele represent a 
diverticulum of the distal common bile duct protruding 
into the duodenal lumen. In addition Antaki et al.[10] 
recently differentiated choledochocele from duodenal 
duplication: the first one, lined with biliary mucosa, 
appears as a dilatation proximal to the papilla. In contrast, 
duodenal duplication is lined by duodenal mucosa and 
it protrudes distally to the papilla sharing a portion of 
its circumference with the duodenal wall. More variants 
of choledochocele were described by Kagiyama et 
al.[11] on the basis of endoscopic retrograde cholangio-
pancreatography (ERCP) findings. 
Figure 2
Classification of Choledochocel
Note. Type A1: a common opening of pancreatic duct (PD) and CBD 
into the cyst. Type A2: distinct opening of PD and CBD. Type A3: small 
and intramural choledochocele. Type B: the ampulla empties into the 
duodenum and the choledochocele represents a diverticulum of the distal 
common bile duct.
The etiology is still  debated: both congenital 
and acquired origins are proposed. Some authors 
describe choledochocele as an abnormal embryonic 
development [8, 12-13],  others consider dysfunction 
of  the  sphincter  of  Oddi ,  papi l lary  s tenosis  or 
inflammation and reflux of pancreatic juices as the 
main cause of the common bile duct dilatation.[1, 8, 14-15] 
We present a case of choledochocele initially 
interpreted as a choledocholithiasis and then recognized 
by ERCP and treated with an endoscopic sphincterotomy 
(ES). A systematic review of the literature referred to 
choledochocele cases was also performed, in order to 
highlight its clinical, diagnostic and therapeutic aspects. 
It’s our aim to draw attention to the differences that occur 
between choledochocele and Todani types I, II, IV and V 
choledochal cysts, to demonstrate that choledochocele is a 
distinct entity. 
CASE REPORT 
A 66 years old man treated with antihypertensive drugs 
and affected by known gallbladder lithiasis, was admitted 
to our Emergency Room for colic abdominal pain 
associated with nausea, alimentary vomit and fever. At 
the physical examination his skin and sclera were yellow-
stained and he had tenderness in the right hypochondrium 
and was positive for Murphy’s sign. The blood tests 
showed abnormal liver function: aspartate transaminase 
594 U/L [normal 2-37 U/L], alanine transaminase 551 U/
L [normal 2-40 U/L], gamma-glutamyltranspeptidase 493 
U/L [normal 11-50 U/L]. The patient had a mild jaundice 
with a total bilirubin of 2.54 mg/dL [normal 0.20-1.20 mg/
dL] and direct bilirubin of 1.62 mg/dL [normal <0.3 mg/
dL]. Alkaline phosphatase was normal such as pancreatic 
function tests; a moderate leucocytosis was present. An 
upper abdominal ultrasonography highlighted a thick-
walled gallbladder with a 2 cm unique stone and a mild 
dilatation of intra and extra-hepatic bile ducts (common 
bile duct diameter was 9 mm). The observation of the 
gallstone associated with the presence of the jaundice and 
the biliary symptoms suggested an initial diagnosis of 
choledocholithiasis. Therefore an ERCP was performed 
and it showed a protruding mucosa fold covering the 
major papilla. The catheterization of the papilla and the 
filling with contrast medium didn’t show any stones 
in the CBD but highlighted a saccular dilatation of the 
distal common bile duct of about 15 mm referring to 
choledochocele type A (Figures 3 and 4). An endoscopic 
sphincterotomy was carried out to unroof the superior 
part of the intramural segment of the choledochocele; in 
addition several biopsies of the mucosa were performed. 
The histopathological examination revealed normal 
tissue. Four days after ES the patient underwent a 
trans naso-biliary tube cholangiography that showed a 
reduction of the biliary ducts dilatation, the resolution 
of the choledochocele and it confirmed the gallstones. 
For this reason, after three days the patient underwent 
a laparoscopic cholecystectomy. The postoperative 
recovery was uneventful and two days after surgery the 
patient was discharged. Ten days and 13 months after 
surgery the patient underwent a magnetic resonance 
cholangio-pancreatography that showed the complete 
resolution of the choledochocele (Figure 5). At a four 
years follow-up the patient is clinically asymptomatic 
and in good health. 
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Figure 3
Endoscopic Retrograde Cholangio-Pancreatography 
and Opacification of the Biliary Tree With Contrast 
Medium That Shows the Dilatation of Terminal 
Common Bile Duct (Choledochocele)
Figure 4
Endoscopic Retrograde Cholangio-Pancreatography 
and Opacification of the Biliary Tree With Contrast 
Medium That Shows the Dilatation of Terminal 
Common Bile Duct (Choledochocele)
Figure 5
Magnetic Resonance Cholangio-Pancreatography That 
Shows the Complete Resolution of the Choledochocele 
13 Months After Surgery
SYSTEMATIC REVIEW 
Material and Methods 
A systematic research of medical literature was performed 
on PubMed MEDLINE. We considered articles written 
in all languages other than Russian and Chinese, both 
case-reports and internal reviews, directly relevant to 
type III choledochal cysts. Moreover we excluded papers 
describing an exclusive or prevalent pediatric series 
and we limited our search starting from the year 2000, 
focusing on the newest series described in the last 15 
years. In total, 28 publications resulted and 22 of these 
offered detailed data available for the review. Therefore 
we finally collected 105 cases of choledochocele. For each 
case we considered 10 variables: Age, gender, clinical 
manifestation, comorbidities, diagnostic technique, 
treatment, size, complications, hospital stay and months 
of follow up. All the data were compared and analysed; 
when necessary we used the mean values and standard 
deviation. 
RESULTS 
Since year 2000, 105 cases of choledochocele in adult 
patients were described in literature (Tables 1 and 2). In 19 
cases (18%) the gender wasn’t reported. Of the remaining 
cases 33 (38%) were male, 53 (62%) were female; the 
mean patient’s age was 51 (± 20.2), with a range between 
21-77 years.
Abdominal pain and pancreatitis were the main clinical 
manifestations, respectively in 54% and 28% of patients; 
five of these patients presented relapsing pancreatitis. 
Other common symptoms were nausea and vomit (12%), 
jaundice (10%) and cholangitis (6%). Three patients 
presented with cholecystitis, other two with recent weight 
loss, and an abdominal mass was found in one case. 
Different comorbidities were described in many patients: 
choledocholithiasis (24%), cholecystolithiasis (16%), 
anomalous pancreato-biliary duct junction (APBDJ, 
16%), pancreas divisum (13%). Five cases presented 
with biliary or pancreatic stricture, and in two cases other 
types of CC were found. At the time of choledochocele’s 
diagnosis a total of nine patients (10%) resulted in a 
neoplastic affection, of which seven cases (7,8%) were 
malignant neoplasia: one pancreatic adenocarcinoma, two 
gallbladder cancers and four cholangiocarcinomas. 
All patients underwent at first  an Ultrasound 
examination (US) but it was always followed by further 
diagnostic techniques. ERCP was performed in 103 cases 
(98%) and it was always diagnostic. In addition to ERCP, 
magnetic resonance cholangio-pancreatography (MRCP) 
was performed in ten patients and computed tomography 
(CT) scan in six. In two patients the diagnosis was 
obtained only with MRCP. Endoscopic ultrasonography 
(EUS) was performed in one patient.  The mean
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Table 1
Review of literature: Patient population, Symptoms, Signs, Comorbidities, Diagnosis
Author N°pts Sex (f/m) Median Age Clinical manifestations Comorbidities
Diagnostic 
technique
Zhu L et al, 201445 1 F 75 abdominal pain, nausea/vomiting, pancreatitis choledocholithiasis, biliary stricture CT, ERCP
Popova-Jovanovska R 
et al, 201239 1 F 60 abdominal pain, jaundice biliary neoplasm MRCP, ERCP
Garrido A et al, 201246 1 M 77 abdominal pain, nausea/vomiting, cholangitis pancreas divisum ERCP
Ulas M et al, 201228 3 n.a. n.a. abdominal pain, cholangitis no ERCP
Ziegler KM et al, 20106 28* 16/12 50.7
abdominal pain (67%),pancreatitis (46%)
nausea/vomiting (18%), jaundice (11%),
weight loss (7%), abdominal mass (4%)
APBDJ (50%),
pancreas divisum (39%),
biliary stricture (11%), pancreatic 
stricture (4%), biliary neoplasm 
(7%), pancreatic neoplasm (7%)
ERCP
Martìnez-Ordaz JL
et al, 201047 3 n.a. n.a. abdominal pain n.a. ERCP
Wang QG et al, 200948 1 F 66 abdominal pain, pancreatitis, jaundice,cholecystitis cyst type I ERCP
Gordon SR et al, 200949 1 F 23 Pancreatitis no EUS, ERCP
Uribarrena Amezaga R 
et al, 200850 1 n.a. 44 abdominal pain, recurrent pancreatitis no CT, ERCP
Berger A et al, 200731 1 M 70 abdominal pain, nausea/vomiting cholecysto-choledochal lithiasis ERCP
Can MF et al, 200651 1 M 21 abdominal pain, nausea/vomiting no
CT, MRCP, 
ERCP
Horaguchi J et al, 
200523 21 14/7 68.5
abdominal pain (57%),
pancreatitis (19%),
jaundice (10%), cholecystitis (5%)
choledocholithiasis (43%), 
cholecystolithiasis (38%),  
gallbladder carcinoma (10%),
cholangiocarcinoma(5%)
ERCP
Safioleas MC et al, 
200552 1 F n.a. n.a. cholecystolithiasis ERCP
Garcìa-Cano J et al, 
200553 1 M 57 abdominal pain no ERCP
Park DH et al, 200554 11 n.a. n.a. n.a. n.a. ERCP(100%),MRCP (73%)
Naga MI et al, 200440 2 0/2 50.5 jaundice, cholangitis no ERCP
Jordan PH et al, 200455 1 n.a. n.a. no n.a. ERCP
Katsinelos P et al, 
2003[36] 2 2/0 59.5 abdominal pain, recurrent pancreatitis no CT, ERCP
Rabie ME et al, 2002[56] 1 M 25 abdominal pain biliary mud CT, ERCP
Park KB et al, 2001[24] 21 14/7 67 recurrent pancreatitis (10%)
choledocholithiasis (48%),  
colecystolithiasis (19%),
Klatskin tumour (5%),
cyst type I (5%)
ERCP
De Backer AI et al, 
2000[26] 1 F 22
abdominal pain, nausea/vomiting, 
pancreatitis, cholecystitis no
MRI,
MRCP
Adamek HE et al, 
2000[27] 1 F 25 abdominal pain,  nausea/vomiting no MRCP
Note. N°pts number of patients; f female; m male; APBDJ anomalous pancreato-biliary duct junction; EUS endoscopic ultrasonography; n.a. not 
avaible, *including 3 pediatric cases.
choledochocele size of dilatation, described only in eight 
cases, was 36 mm (range 14-50).
As shown in Table 2, the treatment mainly performed 
for choledochocele was ES (92%): It failed in seven 
cases and a surgical approach was then required because 
of bleeding or for difficult visualization that didn’t 
permit the cannulation of Vater’s papilla. In six cases 
(6%) an open surgery was chosen since the beginning: 
One patient underwent a pancreaticoduodenectomy 
(Whipple procedure), one patient underwent an excision 
of the cyst followed by cholecystectomy and Roux-en-Y 
choledochojejunostomy and in one case a cholecysto-
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Table 2
Review of literature: Treatment, Complications and Follow Up
Author N°pts Treatment Size (mm) Complications
Hospital
stay
(days)
FOLLOW 
UP (months)
Zhu L et al, 2014[45] 1 ES n.a. no n.a. n.a
Popova-Jovanovska R et al, 2012[39] 1 Pancreatico-duodenectomy 50 no n.a. 60
Garrido A et al, 2012[4]6 1 ES n.a. no n.a. 6
Ulas M et al, 2012[28] 3 ES <30 no n.a. n.a.
Ziegler KM et al, 2010[6] 28* ES (68%), ES+open surgery (21%), open surgery (11%) n.a. n.a. 7 41
Martìnez-Ordaz JL
et al, 201047 3 ES n.a. no n.a. 48
Wang QG et al, 2009[48] 1 Cystectomy + cholecystectomy with Roux-en-Y choledocho-jejunostomy n.a. no 20 n.a.
Gordon SR et al, 2009[49] 1 ES 20 no 1 3
Uribarrena Amezaga R et al, 2008[50] 1 ES n.a. no n.a. 36
Berger A et al, 2007[31] 1 ES 40 no n.a. 6
Can MF et al., 2006[51] 1 ES + duodenotomy 50 no n.a. 2
Horaguchi J et al., 2005[23] 21 ES 6 n.a. n.a. n.a.
Safioleas et al., 2005[52] 1 ES n.a. no n.a. 54
Garcìa-Cano et al., 2005[53] 1 ES n.a. no n.a. 24
Park et al., 2005[54] 11 ES n.a. n.a. n.a. 36
Naga et al., 2004[40] 2 ES n.a. no n.a. 36
Jordan et al., 2004[55] 1 Not treated n.a. n.a. n.a. n.a.
Katsinelos et al., 2003[36] 2 ES n.a. no 11 18
Rabie et al., 2002[56] 1 Duodenectomy + cyst marsupialization + cholecystectomy 50 no n.a. 8
Park et al., 2001[24] 21 ES n.a. n.a. n.a. n.a.
De Backer et al., 2000[26] 1 Medical therapy for pancreatitis n.a. no n.a. n.a.
Adamek et al., 2000[27] 1 ES n.a. no n.a. 6
Note. N°pts number of patients; ES endoscopic sphincterotomy; mm millimeter; n.a. not avaible, *including 3 pediatric cases.
duodenectomy with marsupialization of the cyst was 
carried out. In three patients the surgical procedure was 
not described. There were no post-operative complications 
in the available data and the mean hospital stay was 1 day 
for ES and 14 days for surgery. Two cases didn’t undergo 
any invasive procedures: One case was asymptomatic 
therefore was not treated with surgical neither with 
medical therapy and one patient received only medical 
therapy to resolve the pancreatitis and refused further 
invasive procedures. 
The mean follow-up time was 26 months (range 2-60). 
Among all studies, 14 reported long-term outcomes after 
treatment: 84% of these patients had a complete resolution 
of symptoms and didn’t show clinical or endoscopic 
recurrence. Two patients (4.5%) developed biliary tumour 
(one cholangiocarcinoma and one ampullar carcinoma) at 
36 and 53 months after the sphincterotomy. Both patients 
died 3 months after diagnosis. Five patients (11%) died 
for unknown reasons.
DISCUSSION 
The present study is a review concerning the peculiar 
features of choledochocele obtained by the most 
recent international literature. Summarizing all data 
we first noticed that demographic characteristics of 
choledochocele differ from those of other types of cysts: 
We obtained a sex ratio of 1,6:1 that is notably lower than 
the one reported in the literature for all CC (4:1)[5], in 
addition our mean age was 51 years according with Law 
et al.7 who reported the same mean age confirming that 
the population presenting choledochocele is substantially 
older than the one affected by other type of CC (mean age 
29 years[7]).
Even the clinical manifestations are peculiar: whereas 
CDC is frequently associated with obstructive jaundice 
and cholangitis, the most frequent clinical manifestation 
of choledochocele, beside an aspecific abdominal pain, 
was pancreatitis that regarded 28% of patients with which 
the 19% presented relapsing pancreatitis. Previously 
Sarris et al.[9] and Masetti et al.[16] in two large reviews 
published respectively in 1988 and 1996, reported an 
incidence of pancreatitis associated with choledochocele 
that reached the value of 38%. The pathogenesis of this 
occurrence was first proposed in 1980 when Goldberg 
et al[17].  suggested that the increased ductal pressure and 
the biliary reflux caused by the cystic dilatation could 
determine an obstruction of the pancreato-biliary outflow. 
Nowadays it still remains the most accepted hypothesis 
and some authors even identify choledochocele as a cause 
of recurrent pancreatitis[18]. 
Anomalous pancreato-biliary duct junction (APBDJ) 
occurs in 50% to 80% of patients[5] with choledochal 
cyst especially in type I and IV[7]. APBDJ is defined as a 
Copyright © Canadian Research & Development Center of Sciences and Cultures
6
Choledochocele: Choledochal Cyst Ora Distinct Entity?
common channel greater than 15-20 mm or as a junction 
between the pancreatic and biliary ducts outside the 
duodenal wall[19-20]. Ziegler et al.[6] observed that APBDJ 
are significantly less frequent in choledochocele than 
in other cysts. According to this finding APBDJ was 
detected in only 16% of all cases reviewed demonstrating 
that the association between choledochal cysts and 
APBDJ is well established for all types of CDC except for 
choledochocele. This observation is important since one 
third of patients with APBDJ present a biliary neoplasia.[20] 
APBDJ is considered as an independent risk factor for the 
onset of tumour in the biliary tract because the pancreato-
biliary reflux causes a chronic inflammation of the 
tissue and the development of the sequence hyperplasia-
dysplasia-carcinoma[21-22]. Therefore it’s not surprising that 
the incidence of cholangiocarcinoma in our series is lower 
than the one associated with other type of cysts reported 
in literature (4% versus 10%-30% [5, 21]).
Many di fferent  cr i ter ia  for  the  diagnosis  of 
choledochocele are reported in literature[23-25], but a 
lack of a univocal definition is still present. Moreover 
no minimum diameter of the cystic dilatation has 
been defined but the general assumption is that 
choledochocele’s size should be at least 1 cm, otherwise it 
is considered as a simple dilatation of the common biliary 
channel. 
Since the majority of patients of our cohort initially 
presented upper abdominal pain, US was the first 
diagnostic tool used but it never allowed to reach the 
diagnosis because the cysts were too small to visualize. 
Nevertheless it offered important information about the 
presence of gallbladder stones, dilatation of the biliary 
tree and the presence of inflammation or neoplasia. Cross-
sectional imaging like MRCP was scarcely used: It was 
successfully diagnostic in only two patients[26-27] since in 
the other cases they were always followed by endoscopy. 
Even if MRCP is considered the gold standard for the 
investigation of all type of choledochal cysts[22, 28], ERCP 
is the most accurate and accepted technique for the 
diagnosis of choledochocele with a reported sensitivity of 
97%[16]. It is considered the most precise method showing 
the localization and extension of the cyst, and it can 
confirm the presence or absence of APBDJ.[29-30] For these 
reasons, and because it permits the definitive management 
of the disease, endoscopy remains the most widely 
diagnostic and therapeutic tool used. 
Historically surgical treatment was considered the 
standard management to excise potentially premalignant 
tissue from CDC[7]. This therapeutic strategy is now 
rarely used in the treatment of choledochocele and has 
been progressively replaced by endoscopic management. 
The lower risk of malignancy arising in choledochocele 
justifies the use of this more conservative technique.
[31-32] Endoscopic sphincterotomy (ES) as a therapy for 
choledochocele was first described by Dehyle and Meyer 
in 1974[33] followed by Siegel et al.[34] and Nagasawa et 
al.[35] and it consists in the incision of the mucosal tissue 
roofing the cyst with a sphincterotome[36]. This procedure 
allows the drainage of the biliary stagnation, which is 
supposed to be partly responsible for the degeneration 
of the cyst[37]. For this reason, given the possibility that 
pancreatic and biliary secretions can mix within the cystic 
dilatation and create a precancerous state, sphincterotomy 
is recommended even in asymptomatic patients[38]. In 
our study, the 92% of patients underwent an endoscopic 
sphincterotomy with a failure in only 7% of cases, 
demonstrating that this approach is safe, feasible and it’s 
accepted to be the treatment of choice for choledochocele. 
There are controversial opinions about the need for 
a long-term follow up considering that choledochocele 
seldom co-exists with carcinoma. Even though the risk of 
malignant degeneration of the biliary tract demonstrated 
to be relatively low if compared with other type of cysts, 
at the time of diagnosis the total incidence of associated 
benign and malignant neoplasia of the biliary and 
pancreatic tissue reached the value of 10%. In addition 
4.5% of the population presented a biliary tumour a long 
time after ES. Therefore, as several Authors previously 
suggested[7, 39--42], we propose that a long-term surveillance 
may be done and it should include periodic endoscopy 
and mucosal biopsies to definitely exclude a possible 
malignancy. 
Choledochocele has been always included in Todani’s 
classification as type III choledochal cyst but several 
authors[6-7, 23-43], beginning from Wearn et al.[44] in 1982, 
suggested to exclude it from the group of choledochal 
cysts. The aim of this review was to discuss this possibility 
and, on the basis of the peculiar demographics data and 
clinical presentation, the lower risk of malignancy and the 
different standard procedure for diagnosis and treatment, 
choledochocele should be considered as a distinct 
pathological entity with its own features even if included 
in choledochal cysts classification.
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